Gaucher Disease Latest Advances

Find the Latest Research About Gaucher Disease

Last Updated: 04/28/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 5910 publications

Reference intervals for lysosomal glucocerebrosidase activity in the healthy population.

Reference intervals for lysosomal glucocerebrosidase activity in the healthy population.

Journal: Scandinavian journal of clinical and laboratory investigation

Published: March 15, 2026

Honoring Padma Shri Professor I.C. Verma - A Tribute from the Indian Medical Advisory Board (IMAB).

Honoring Padma Shri Professor I.C. Verma - A Tribute from the Indian Medical Advisory Board (IMAB).

Journal: Indian journal of pediatrics

Published: March 02, 2026

Increased intervals in enzyme replacement therapy for stable type 1 Gaucher disease: A non-inferiority sequential trial emulation.

Increased intervals in enzyme replacement therapy for stable type 1 Gaucher disease: A non-inferiority sequential trial emulation.

Journal: Journal of internal medicine

Published: February 28, 2026

Gaucher disease masked by childhood splenectomy: a forty-year diagnostic delay.

Gaucher disease masked by childhood splenectomy: a forty-year diagnostic delay.

Journal: Polish archives of internal medicine

Published: February 25, 2026

Effect of Glu235Ser on enzyme performance and in vitro characterization of human β-glucocerebrosidase in a Pichia pastoris.

Effect of Glu235Ser on enzyme performance and in vitro characterization of human β-glucocerebrosidase in a Pichia pastoris.

Journal: International journal of biological macromolecules

Published: February 22, 2026

Improvement of Bone Mineral Density in Patients with Type 1 Gaucher Disease Treated with Velaglucerase Alfa: Results from Clinical Studies.

Improvement of Bone Mineral Density in Patients with Type 1 Gaucher Disease Treated with Velaglucerase Alfa: Results from Clinical Studies.

Journal: Journal of clinical medicine

Published: January 19, 2026

Real-World Effectiveness and Safety of Eliglustat in Adult Patients with Gaucher Disease Type 1: A Multicenter Retrospective Study in China.

Real-World Effectiveness and Safety of Eliglustat in Adult Patients with Gaucher Disease Type 1: A Multicenter Retrospective Study in China.

Journal: Journal of clinical medicine

Published: January 15, 2026

Phenotypic Spectrum of Type 2-3 Gaucher Disease: A Case Study in the Balkan Genotype.

Phenotypic Spectrum of Type 2-3 Gaucher Disease: A Case Study in the Balkan Genotype.

Journal: The American journal of case reports

Published: January 15, 2026

Unveiling an Uncommon Glucosylceramidase (GBA) Mutation: Gaucher Disease Due to p.Ser276Phe Substitution.

Unveiling an Uncommon Glucosylceramidase (GBA) Mutation: Gaucher Disease Due to p.Ser276Phe Substitution.

Journal: Cureus

Published: January 13, 2026

Safety and Efficacy of Ambroxol Therapy in Polish Patients with Gaucher Disease.

Safety and Efficacy of Ambroxol Therapy in Polish Patients with Gaucher Disease.

Journal: Life (Basel, Switzerland)

Published: January 09, 2026

Disease severity assessment and standardized follow-up for Gaucher disease

Disease severity assessment and standardized follow-up for Gaucher disease

Journal: Zhonghua nei ke za zhi

Published: January 08, 2026

A bioinformatics-guided analytical approach for drug repositioning: Colchicine as a candidate for gaucher disease treatment.

A bioinformatics-guided analytical approach for drug repositioning: Colchicine as a candidate for gaucher disease treatment.

Journal: Analytical biochemistry

Published: January 01, 2026

Showing 1-12 of 5,910

Last Updated: 04/28/2026